RxSight
RXST
169 hedge funds and large institutions have $1.17B invested in RxSight in 2023 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 56 increasing their positions, 46 reducing their positions, and 8 closing their positions.
525% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 8
64% more capital invested
Capital invested by funds: $718M → $1.17B (+$457M)
32% more funds holding
Funds holding: 128 → 169 (+41)
22% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 46
12% more call options, than puts
Call options by funds: $5.58M | Put options by funds: $4.99M
8.99% more ownership
Funds ownership: 72.24% → 81.23% (+9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.8M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.3M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$12.2M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$10.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$10.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$24.6M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$15.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.1M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$9.08M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$8.13M |
RXST Hedge Fund Activity: Q4 2023 in Review
169 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2023, worth a combined $1.17B — up 64% from $718M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new RXST positions and 8 closed out — a net gain of 42 holders — while 56 added to existing stakes and 46 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $34.8M. The largest seller was Millennium Management, cutting an estimated $24.6M.
- 169 institutional investors held RxSight (RXST) as of Q4 2023, up from 128 in Q3 2023.
- Funds reported $1.17B of RxSight stock for Q4 2023, up 64% quarter-over-quarter.
- 50 funds opened new RxSight positions in Q4 2023 and 8 closed out, a net change of +42 holders.
- The largest RxSight buyer in Q4 2023 was Fidelity Investments, an estimated $34.8M added.
- The largest RxSight seller in Q4 2023 was Millennium Management, an estimated $24.6M sold.
Based on aggregated 13F filings for Q4 2023.